MCID: LMB006
MIFTS: 51

Limb-Girdle Muscular Dystrophy malady

Categories: Genetic diseases, Rare diseases, Muscle diseases, Neuronal diseases, Metabolic diseases

Aliases & Classifications for Limb-Girdle Muscular Dystrophy

About this section

Aliases & Descriptions for Limb-Girdle Muscular Dystrophy:

Name: Limb-Girdle Muscular Dystrophy 10 21 45 22 23 12
Muscular Dystrophies, Limb-Girdle 36 24 65
Limb Girdle Muscular Dystrophy 10 45 22
Lgmd 21 22 23
Leyden-Mbius Muscular Dystrophy 10
 
Myopathic Limb-Girdle Syndrome 23
Muscular Dystrophy Limb-Girdle 47
Erb's Muscular Dystrophy 10
Limb-Girdle Syndrome 23
Limb Girdle 47

Classifications:



External Ids:

Disease Ontology10 DOID:11724
ICD1027 G71.0
SNOMED-CT59 56096001, 93153005
MeSH36 D049288
NCIt42 C84828
UMLS65 C0686353

Summaries for Limb-Girdle Muscular Dystrophy

About this section
NIH Rare Diseases:45 Limb-girdle muscular dystrophy is a group of disorders which affect the voluntary muscles around the hips and shoulders. the conditions are progressive, leading to a loss of muscle strength and bulk over a number of years. onset may occur in childhood, adolescence, young adulthood, or even later. males and females are affected in equal numbers. most forms of limb girdle muscular dystrophy are inherited in an autosomal recessive manner. several rare forms are inherited in an autosomal dominant pattern. while there are no treatments which directly reverse the muscle weakness associated with this condition, supportive treatment can decrease the complications. there are at least 20 different types of limb-girdle muscular dystrophy. last updated: 12/17/2015

MalaCards based summary: Limb-Girdle Muscular Dystrophy, also known as muscular dystrophies, limb-girdle, is related to muscular dystrophy, limb-girdle, type ic and muscular dystrophy, limb-girdle, type 1b. An important gene associated with Limb-Girdle Muscular Dystrophy is DYSF (Dysferlin), and among its related pathways are Smooth Muscle Contraction and Hypertrophic cardiomyopathy (HCM). Affiliated tissues include lung, breast and testes, and related mouse phenotypes are cardiovascular system and homeostasis/metabolism.

Disease Ontology:10 A muscular dystrophy that is characterized by weakening of the muscles of the hip and shoulders which comprise the limb girdle muscles.

Genetics Home Reference:23 Limb-girdle muscular dystrophy is a term for a group of diseases that cause weakness and wasting of the muscles in the arms and legs. The muscles most affected are those closest to the body (proximal muscles), specifically the muscles of the shoulders, upper arms, pelvic area, and thighs.

Wikipedia:68 Limb-girdle muscular dystrophy (LGMD) or Erb\'s muscular dystrophy is a genetically and clinically... more...

GeneReviews summary for NBK1408

Related Diseases for Limb-Girdle Muscular Dystrophy

About this section

Diseases in the Limb-Girdle Muscular Dystrophy family:

Muscular Dystrophy, Limb-Girdle, Type 1b Muscular Dystrophy, Limb-Girdle, Type 2b
Muscular Dystrophy, Limb-Girdle, Type 2j Muscular Dystrophy, Limb-Girdle, Type 2r
Muscular Dystrophy, Limb-Girdle, Type Ic Muscular Dystrophy, Limb-Girdle, Type 1h
Muscular Dystrophy, Limb-Girdle, Type 2e Limb-Girdle Muscular Dystrophy, Type 1g
Muscular Dystrophy, Limb-Girdle, Type 1a Muscular Dystrophy, Limb-Girdle, Type 2f
Muscular Dystrophy, Limb-Girdle, Type 1f Muscular Dystrophy, Limb-Girdle, Type 1e
Muscular Dystrophy, Limb-Girdle, Type 2q Muscular Dystrophy, Limb-Girdle, Type 2h
Muscular Dystrophy, Limb-Girdle, Type 2l Muscular Dystrophy, Limb-Girdle, Type 2c
Muscular Dystrophy, Limb-Girdle, Type 2a Muscular Dystrophy, Limb-Girdle, Type 2g
Muscular Dystrophy, Limb-Girdle, Type 2d Limb-Girdle Muscular Dystrophy Type 1d
Limb-Girdle Muscular Dystrophies, Autosomal Dominant Limb-Girdle Muscular Dystrophies, Autosomal Recessive
Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2d Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a
Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2h Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2r
Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2u Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1a
Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1b Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2f
Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2b Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2g

Diseases related to Limb-Girdle Muscular Dystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 380)
idRelated DiseaseScoreTop Affiliating Genes
1muscular dystrophy, limb-girdle, type ic34.1CAV3, DYSF
2muscular dystrophy, limb-girdle, type 1b33.9CAV3, LMNA
3muscular dystrophy, limb-girdle, type 2b32.4CAPN3, CAV3, DYSF, MYOT, SGCA, SGCB
4becker muscular dystrophy30.8CAV3, SGCA, SGCD
5histiocytoma30.5CAV3, DYSF, MYOT
6limb-girdle muscular dystrophy, type 1g13.0
7limb-girdle muscular dystrophy type 1d12.8
8limb-girdle muscular dystrophies, autosomal dominant12.7
9autosomal recessive limb-girdle muscular dystrophy type 2a12.7
10autosomal recessive limb-girdle muscular dystrophy type 2h12.7
11autosomal recessive limb-girdle muscular dystrophy type 2f12.7
12limb-girdle muscular dystrophies, autosomal recessive12.7
13collagen type vi-related autosomal dominant limb-girdle muscular dystrophy12.7
14autosomal recessive limb-girdle muscular dystrophy type 2d12.7
15autosomal recessive limb-girdle muscular dystrophy type 2r12.7
16autosomal recessive limb-girdle muscular dystrophy type 2u12.7
17autosomal dominant limb-girdle muscular dystrophy type 1a12.7
18autosomal dominant limb-girdle muscular dystrophy type 1b12.7
19autosomal recessive limb-girdle muscular dystrophy type 2b12.7
20autosomal recessive limb-girdle muscular dystrophy type 2g12.7
21limb-girdle muscular dystrophy due to pomk deficiency12.7
22muscular dystrophy, limb-girdle, type 2e12.5
23muscular dystrophy-dystroglycanopathy , type c, 112.5
24muscular dystrophy, limb-girdle, type 2q12.4
25muscular dystrophy-dystroglycanopathy , type c, 512.4
26muscular dystrophy, limb-girdle, type 2c12.4
27muscular dystrophy, limb-girdle, type 1e12.4
28muscular dystrophy, limb-girdle, type 1f12.4
29muscular dystrophy, limb-girdle, type 2j12.4
30muscular dystrophy, limb-girdle, type 2l12.4
31calpainopathy12.3
32muscular dystrophy, limb-girdle, type 1h12.3
33muscular dystrophy-dystroglycanopathy , type c, 312.3
34muscular dystrophy, limb-girdle, type 1a12.3
35muscular dystrophy, limb-girdle, type 2f12.3
36muscular dystrophy, limb-girdle, type 2h12.3
37muscular dystrophy, limb-girdle, type 2g12.3
38muscular dystrophy, limb-girdle, type 2a12.2
39muscular dystrophy, limb-girdle, type 2d12.2
40muscular dystrophy, limb-girdle, type 2r12.1
41muscular dystrophy-dystroglycanopathy , type c, 412.0
42muscular dystrophy-dystroglycanopathy , type c, 212.0
43inclusion body myopathy with early-onset paget disease and frontotemporal dementia 112.0
44epidermolysis bullosa simplex with muscular dystrophy12.0
45epidermolysa bullosa simplex with muscular dystrophy12.0
46muscular dystrophy-dystroglycanopathy , type c, 1411.9
47muscular dystrophy-dystroglycanopathy , type c, 911.9
48myopathy, myofibrillar, 111.7
49delta-sarcoglycanopathy11.7
50inclusion body myopathy with early-onset paget disease and frontotemporal dementia11.7

Graphical network of the top 20 diseases related to Limb-Girdle Muscular Dystrophy:



Diseases related to limb-girdle muscular dystrophy

Symptoms for Limb-Girdle Muscular Dystrophy

About this section

Drugs & Therapeutics for Limb-Girdle Muscular Dystrophy

About this section

Drugs for Limb-Girdle Muscular Dystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Lisinoprilapproved, investigationalPhase 2, Phase 311683915-83-75362119
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Carace
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
LPR
LS-118899
Linopril
Linvas
Lipril
Lisinal
Lisinopril
Lisinopril (INN)
 
Lisinopril (anhydrous)
Lisinopril 10mg
Lisinopril 2.5mg
Lisinopril 20mg
Lisinopril 40mg
Lisinopril 5mg
Lisinopril Dihydrate
Lisinopril anhydrous
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
SMR000544473
SPBio_001351
SPBio_002481
SPECTRUM1501217
Sinopril
Sinopryl
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Spectrum_000497
TL8005499
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
Zestril (TN)
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
lisinopril
2Immunosuppressive AgentsPhase 2, Phase 310422
3Immunologic FactorsPhase 2, Phase 318483
4Anti-Inflammatory AgentsPhase 2, Phase 38478
5DeflazacortPhase 2, Phase 31214484-47-0
6Protective AgentsPhase 2, Phase 35651
7VitaminsPhase 2, Phase 33857
8Protease InhibitorsPhase 2, Phase 34558
9UbiquinonePhase 2, Phase 392
10Trace ElementsPhase 2, Phase 33900
11HIV Protease InhibitorsPhase 2, Phase 34558
12Angiotensin-Converting Enzyme InhibitorsPhase 2, Phase 3634
13MicronutrientsPhase 2, Phase 33901
14Antihypertensive AgentsPhase 2, Phase 33618
15
Coenzyme Q10NutraceuticalPhase 2, Phase 3104303-98-05281915
Synonyms:
(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
(all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
4-Ethyl-5-fluoropyrimidine
Aqua Q 10L10
Aqua Q10
Bio-Quinon
Bio-Quinone Q10
CoQ10
Coenzyme Q10
Ensorb
Kaneka Q10
Kudesan
 
Li-Q-Sorb
Liquid-Q
Neuquinon
Neuquinone
PureSorb Q 40
Q 10AA
Q-Gel
Q-Gel 100
Ubidecarenone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
Ubiquinone-10
Unbiquinone
Unispheres Q 10
16VaccinesPhase 16085

Interventional clinical trials:

(show all 23)
idNameStatusNCT IDPhase
1Deflazacort in DysferlinopathiesCompletedNCT00527228Phase 2, Phase 3
2Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular DystrophiesEnrolling by invitationNCT01126697Phase 2, Phase 3
3Study Evaluating MYO-029 in Adult Muscular DystrophyCompletedNCT00104078Phase 1, Phase 2
4The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular DystrophiesRecruitingNCT02579239Phase 1, Phase 2
5Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCAEnrolling by invitationNCT01976091Phase 1, Phase 2
6Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2CCompletedNCT01344798Phase 1
7Stem Cell Therapy in Limb Girdle Muscular DystrophyCompletedNCT02050776Phase 1
8Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)CompletedNCT00494195Phase 1
9Safety Study of Transvenous Limb Perfusion in Human Muscular DystrophyCompletedNCT00873782Phase 1
10Cell Therapy in Limb Girdle Muscular DystrophyRecruitingNCT02245711Phase 1
11rAAVrh74.MHCK7.DYSF.DV for Treatment of DysferlinopathiesRecruitingNCT02710500Phase 1
12Evaluation of Limb-Girdle Muscular DystrophyCompletedNCT00893334
13MRI and Muscle Involvement in Patients With Mutations in GMPPBCompletedNCT02635321
14Cardiac Outcome Measures in Children With Muscular DystrophyCompletedNCT01066455
15Cardiac Magnetic Resonance in Children With Muscular DystrophyCompletedNCT01081080
16Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2IRecruitingNCT02165358
17Limb Girdle Muscular Dystrophy (LGMD) Natural HistoryRecruitingNCT01783509
18MRI on Persons With Mutations in POMT2 Gene (LGMD2N)RecruitingNCT02759302
19Molecular Analysis of Patients With Neuromuscular DiseaseRecruitingNCT00390104
20Congenital Muscle Disease Study of Patient and Family Reported Medical InformationRecruitingNCT01403402
21Clinical Trial Readiness for the DystroglycanopathiesRecruitingNCT00313677
22Genetic Characterization of Individuals With Limb Girdle Muscular DystrophyActive, not recruitingNCT00457912
23Clinical Outcome Study for DysferlinopathyActive, not recruitingNCT01676077

Search NIH Clinical Center for Limb-Girdle Muscular Dystrophy


Cochrane evidence based reviews: muscular dystrophies, limb-girdle

Genetic Tests for Limb-Girdle Muscular Dystrophy

About this section

Genetic tests related to Limb-Girdle Muscular Dystrophy:

id Genetic test Affiliating Genes
1 Limb-Girdle Muscular Dystrophy22

Anatomical Context for Limb-Girdle Muscular Dystrophy

About this section

MalaCards organs/tissues related to Limb-Girdle Muscular Dystrophy:

33
Lung, Breast, Testes, Bone, Neutrophil, Endothelial, Colon

Animal Models for Limb-Girdle Muscular Dystrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Limb-Girdle Muscular Dystrophy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053857.8CAPN3, CAV3, LMNA, SGCA, SGCB, SGCD
2MP:00053766.6CAPN3, CAV3, DYSF, FKTN, LMNA, SGCA
3MP:00053696.1CAPN3, CAV3, DYSF, FKTN, LMNA, SGCA

Publications for Limb-Girdle Muscular Dystrophy

About this section

Articles related to Limb-Girdle Muscular Dystrophy:

(show top 50)    (show all 442)
idTitleAuthorsYear
1
INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia. (25736236)
2015
2
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. (25890497)
2015
3
The Regulation of TGFI^1 Induced Fibronectin EDA Exon Alternative Splicing in Human Renal Proximal Tubule Epithelial Cells. (24962218)
2015
4
Inferno: colour Doppler ultrasound sign of orchitis. (24692383)
2014
5
Assessing Systems of Care for US Children with Epilepsy/Seizure Disorder. (24228175)
2013
6
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. (23542734)
2013
7
Functional and Morphological Effects of Grape Seed Proanthocyanidins on Peripheral Neuropathy in Rats with Type 2 Diabetes Mellitus. (24343984)
2013
8
FLQAI - A Questionnaire on Quality of Life in Fecal Incontinence: German translation and validation of Rockwood et al.'s (2000) Fecal Incontinence Quality of Life Scale (FIQLS). (22760677)
2012
9
Spinal epidural angiolipoma: A rare cause of spinal cord compression. (23188989)
2012
10
Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin. (22575358)
2012
11
Primary intracranial leiomyosarcoma in an HIV-infected patient. (20676716)
2011
12
Metastatic lobular breast cancer presenting as gastric linitis plastica. (21571246)
2011
13
Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasis. (20044025)
2010
14
Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. (19639199)
2009
15
Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. (19012992)
2009
16
Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues. (19373083)
2009
17
Retrospective analysis of children with uveitis treated with infliximab. (18930672)
2008
18
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. (17573119)
2008
19
Diagnostic value of p16INK4a in squamous intraepithelial lesion in gynecologic cytology]. (17980098)
2007
20
Urokinase receptor primes cells to proliferate in response to epidermal growth factor. (17043637)
2007
21
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha. (16352805)
2006
22
Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. (16472361)
2006
23
Duodenal and gastric Dieulafoy's lesions in a patient with type 2A von Willebrand's disease. (15729257)
2005
24
MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. (15509661)
2005
25
Relationship of Helicobacter pylori to Bcl-2 family expression, DNA content, and pathological characteristics of gastric cancer. (16648655)
2005
26
Spinal cord infarction demonstrated by diffusion-weighted magnetic resonance imaging. (15925784)
2005
27
Adult women with mitral valve prolapse are more flexible. (16183767)
2005
28
Design and evaluation of dihydroxytetrahydro-1H-pyrrolo[2,1-c]- [1,4]benzothiazines as conformationally restricted transition-state inhibitors of beta-ribosidases. (16238341)
2005
29
The role of CD30 in the pathogenesis of haematopoietic malignancies. (15251128)
2004
30
Mouse model of X-linked Alport syndrome. (15153557)
2004
31
Non-surgical management of leiomyoma: impact on fertility. (15129053)
2004
32
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. (14553962)
2003
33
NaF induces early differentiation of murine bone marrow cells along the granulocytic pathway but not the monocytic or preosteoclastic pathway in vitro. (12880368)
2003
34
Choroid plexus cyst in a dog. (12174999)
2002
35
Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature. (12498501)
2002
36
In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy. (11174626)
2001
37
Clinical outcome of the modified pi-plasty procedure for sagittal synostosis. (11358093)
2001
38
Histamine receptors on lymphocytes: distribution and functional significance. (11096373)
2000
39
Design of a Gag pentapeptide analogue that binds human cyclophilin A more efficiently than the entire capsid protein: new insights for the development of novel anti-HIV-1 drugs. (10794694)
2000
40
Japanese physicians and the care of adult patients in persistent vegetative state. (10786328)
2000
41
A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin. (10757065)
2000
42
Statins consumption in autonomous communities in Spain: opportunities for savings]. (10547908)
1999
43
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. (10395480)
1999
44
Hypokalemic periodic paralysis: an unusual cause. (9251321)
1996
45
Evidence for the absence of intron H of the histidine-rich glycoprotein (HRG) gene: genetic mapping and in situ localization of HRG to chromosome 3q28-q29. (8188234)
1994
46
Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. (3474609)
1987
47
Indigenous strongyloidiasis in Nottingham. (3109595)
1987
48
Congenital subvalvular pulmonic stenosis in a cat. (7190749)
1980
49
50

Variations for Limb-Girdle Muscular Dystrophy

About this section

Expression for genes affiliated with Limb-Girdle Muscular Dystrophy

About this section
Search GEO for disease gene expression data for Limb-Girdle Muscular Dystrophy.

Pathways for genes affiliated with Limb-Girdle Muscular Dystrophy

About this section

Pathways related to Limb-Girdle Muscular Dystrophy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
110.0CAV3, DYSF
2
Show member pathways
8.8LMNA, SGCA, SGCB, SGCD, SGCG

GO Terms for genes affiliated with Limb-Girdle Muscular Dystrophy

About this section

Cellular components related to Limb-Girdle Muscular Dystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1T-tubuleGO:00303159.9CAPN3, DYSF
2dystrophin-associated glycoprotein complexGO:00160109.7SGCA, SGCB, SGCD
3sarcolemmaGO:00423839.2CAV3, DYSF, MYOT, SGCB
4cytoskeletonGO:00058569.0SGCA, SGCB, SGCD, SGCG

Biological processes related to Limb-Girdle Muscular Dystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cardiac muscle cell developmentGO:005501310.1CAV3, SGCB
2muscle organ developmentGO:00075179.8CAPN3, CAV3

Sources for Limb-Girdle Muscular Dystrophy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet